Utilizing the Michigan Neuropathy Screening Instrument for Early Detection of Diabetic Neuropathy
NCT ID: NCT06514846
Last Updated: 2024-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2023-06-01
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diabetic Small Fiber Neuropathy: Clinical, Electrophysiological and Neurosonographic Study
NCT05993871
Neurophysiological, Autonomic, and Sonographic Assessment of Diabetic Peripheral Neuropathy
NCT07306884
Differences In The Severity Of Diabetic Neuropathy Based On Electromyography In Type 2 Diabetes Mellitus Patients With And Without Comorbidities
NCT06573684
Neuromuscular Ultrasound in Correlation to Neurophysiological Findings
NCT04092140
Comparing the Ultrasound Appearance of the Sciatic Nerve With Its Appearance Under a Microscope
NCT02384447
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients Group
Study Population:
Place of study: Participants will be recruited from the diabetes clinic, Sohag university hospital.
Type of the study: Cross-Sectional Comparative study.
Patients:
v Study group: participants of the study will meet the following criteria:
Ø Inclusion criteria:
ü Age: 30-55 y
ü Type of diabetes: Type 2
ü Duration of diabetes: Within 1 Year of diagnosis of Type 2 diabetes mellitus according to World Health Organization 1999 criteria
ü Gender: Both males \& females
Ø Exclusion criteria:
Patients who had known conditions that could present with neuropathy such as hereditary sensory neuropathy, vitamin B12 or folate deficiency, paraneoplastic conditions, autoimmune diseases, uremia, hypothyroidism, and ethanol abuse.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ü Type of diabetes: Type 2
ü Duration of diabetes: Within 1Year of diagnosis of Type 2 diabetes mellitus according to World Health Organization 1999 criteria
Exclusion Criteria
33 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Reda Khalafallah Khalil
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of medecine Sohag university
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Soh-Med-24-06-01MS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.